1. Treatment Strategies, 2) Treat to Target in Rheumatoid Arthritis
نویسندگان
چکیده
منابع مشابه
Incorporating the treat-to-target concept in rheumatoid arthritis.
BACKGROUND Recent publications have proposed revisions to disease classification criteria, new definitions of remission, and guidelines for implementing treat-to-target strategies for the management of patients with rheumatoid arthritis (RA). Despite developments leading to this practice-changing approach, the concept of treat to target has not yet been widely accepted or implemented in managed...
متن کاملTreat to target strategy in rheumatoid arthritis: real benefits.
Treating rheumatoid arthritis (RA) with a goal or «Treat to target» strategy is a therapeutic proposal taken from cardiovascular and endocrine literature. It proposes that the therapeutic target in RA should be a state of remission, or an alternative goal could be a low disease activity. Rheumatologists should measure and register disease activity in every clinical visit and if the goal has not...
متن کاملCharacterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years
INTRODUCTION Treat-to-target (T2T) strategies using a protocol of pre-defined adjustments of disease-modifying anti-rheumatic drugs (DMARDs) according to disease activity improve outcomes for patients with rheumatoid arthritis (RA). However, successful implementation may be limited by deviations from the protocol. The aim of this study was to determine the prevalence of protocol deviation, expl...
متن کاملPsoriatic arthritis: treat-to-target.
Recently, the concept of 'treat-to-target' has emerged as a topic of great interest in rheumatology, particularly as regards the therapeutic approach to patients with rheumatoid arthritis RA). From observational data as well data from controlled clinical trials, there is a body of evidence supporting this idea. Thus, closely monitoring RA patients and adjusting therapies with the goal of achiev...
متن کاملCombination treatment strategies in early rheumatoid arthritis.
Combinations of disease modifying antirheumatic drugs (DMARDs) are increasingly being used in patients with early rheumatoid arthritis (RA) when long term results with sequential DMARD monotherapy are disappointing. Combination DMARD therapy may be more effective than monotherapy, and has no additional short term adverse events. The evidence for using combination DMARD therapy is still weak, ho...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 2012
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.101.2865